Imatinib mesylate has limited activity against the central nervous system involvement of Philadelphia chromosome-positive acute lymphoblastic leukaemia due to poor penetration into cerebrospinal fluid.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples